300138 Stock Overview
Develops and produces natural colors, spice extracts and essential oils, nutritional and pharmaceutical extracts, and oils and protein. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 3/6 |
| Past Performance | 1/6 |
| Financial Health | 3/6 |
| Dividends | 3/6 |
Rewards
Risk Analysis
My Notes
Capture your thoughts, links and company narrative
ChenGuang Biotech Group Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥8.80 |
| 52 Week High | CN¥13.49 |
| 52 Week Low | CN¥6.91 |
| Beta | 0.67 |
| 1 Month Change | 1.73% |
| 3 Month Change | 10.41% |
| 1 Year Change | -31.78% |
| 3 Year Change | -46.92% |
| 5 Year Change | 17.65% |
| Change since IPO | 11.07% |
Recent News & Updates
A Piece Of The Puzzle Missing From ChenGuang Biotech Group Co., Ltd.'s (SZSE:300138) 43% Share Price Climb
Oct 08
ChenGuang Biotech Group (SZSE:300138) Might Be Having Difficulty Using Its Capital Effectively
Sep 30Recent updates
A Piece Of The Puzzle Missing From ChenGuang Biotech Group Co., Ltd.'s (SZSE:300138) 43% Share Price Climb
Oct 08ChenGuang Biotech Group (SZSE:300138) Might Be Having Difficulty Using Its Capital Effectively
Sep 30Return Trends At ChenGuang Biotech Group (SZSE:300138) Aren't Appealing
May 13Impressive Earnings May Not Tell The Whole Story For ChenGuang Biotech Group (SZSE:300138)
Apr 25ChenGuang Biotech Group Co., Ltd. (SZSE:300138) Just Reported, And Analysts Assigned A CN¥17.66 Price Target
Apr 21Shareholder Returns
| 300138 | CN Food | CN Market | |
|---|---|---|---|
| 7D | -2.3% | -1.1% | 0.4% |
| 1Y | -31.8% | 4.2% | 12.3% |
Return vs Industry: 300138 underperformed the CN Food industry which returned 4.2% over the past year.
Return vs Market: 300138 underperformed the CN Market which returned 12.3% over the past year.
Price Volatility
| 300138 volatility | |
|---|---|
| 300138 Average Weekly Movement | 7.7% |
| Food Industry Average Movement | 7.5% |
| Market Average Movement | 8.8% |
| 10% most volatile stocks in CN Market | 13.0% |
| 10% least volatile stocks in CN Market | 5.8% |
Stable Share Price: 300138 has not had significant price volatility in the past 3 months compared to the CN market.
Volatility Over Time: 300138's weekly volatility (8%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2000 | 1,799 | Qingguo Lu | www.cn-cg.com |
ChenGuang Biotech Group Co., Ltd. develops and produces natural colors, spice extracts and essential oils, nutritional and pharmaceutical extracts, and oils and protein. The company offers natural colors, including paprika oleoresin, marigold oleoresin, and turmeric; spice extracts and essential oils, such as capsicum oleoresin, sichuan pepper oil, pepper oleoresin, ginger extract, and cumin oil; lutein, lycopene, grape seed extract, curcumin, inulin, stevioside, and green coffee bean extracts; and grape seed oil, walnut oil, safflower seed oil, flaxseed oil, cottonseed oil, natural lutein, and dephenolized cottonseed protein products. Its products are primarily used in food, cosmetics, baking, beverages, health care, and feed industries.
ChenGuang Biotech Group Co., Ltd. Fundamentals Summary
| 300138 fundamental statistics | |
|---|---|
| Market cap | CN¥4.27b |
| Earnings (TTM) | CN¥149.87m |
| Revenue (TTM) | CN¥6.93b |
28.4x
P/E Ratio0.6x
P/S RatioIs 300138 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 300138 income statement (TTM) | |
|---|---|
| Revenue | CN¥6.93b |
| Cost of Revenue | CN¥6.62b |
| Gross Profit | CN¥306.21m |
| Other Expenses | CN¥156.34m |
| Earnings | CN¥149.87m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.31 |
| Gross Margin | 4.42% |
| Net Profit Margin | 2.16% |
| Debt/Equity Ratio | 129.8% |
How did 300138 perform over the long term?
See historical performance and comparisonDividends
1.5%
Current Dividend Yield46%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/25 15:31 |
| End of Day Share Price | 2024/12/25 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
ChenGuang Biotech Group Co., Ltd. is covered by 7 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Siyuan Dong | Changjiang Securities Co. LTD. |
| Wendan Wang | China International Capital Corporation Limited |
| Guang Yao Chen | Founder Securities Co., Ltd. |